Gladwin MT - Search Results

1

Liver injury is associated with mortality in sickle cell disease.

Feld JJ, Kato GJ, Koh C, Shields T, Hildesheim M, Kleiner DE, Taylor JG 6th, Sandler NG, Douek D, Haynes-Williams V, Nichols JS, Hoofnagle JH, Jake Liang T, Gladwin MT, Heller T. Feld JJ, et al. Among authors: gladwin mt. Aliment Pharmacol Ther. 2015 Oct;42(7):912-21. doi: 10.1111/apt.13347. Epub 2015 Aug 3. Aliment Pharmacol Ther. 2015. PMID: 26235444 Free PMC article.

2

The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment.

Gladwin MT, Schechter AN, Shelhamer JH, Ognibene FP. Gladwin MT, et al. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1368-76. doi: 10.1164/ajrccm.159.5.9810094. Am J Respir Crit Care Med. 1999. PMID: 10228097 Review. No abstract available.

3

Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity.

Gladwin MT, Schechter AN, Shelhamer JH, Pannell LK, Conway DA, Hrinczenko BW, Nichols JS, Pease-Fye ME, Noguchi CT, Rodgers GP, Ognibene FP. Gladwin MT, et al. J Clin Invest. 1999 Oct;104(7):937-45. doi: 10.1172/JCI7637. J Clin Invest. 1999. PMID: 10510334 Free PMC article.

4

Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation.

Gladwin MT, Ognibene FP, Pannell LK, Nichols JS, Pease-Fye ME, Shelhamer JH, Schechter AN. Gladwin MT, et al. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):9943-8. doi: 10.1073/pnas.180155397. Proc Natl Acad Sci U S A. 2000. PMID: 10954746 Free PMC article.

5

Nitric oxide therapy in sickle cell disease.

Gladwin MT, Schechter AN. Gladwin MT, et al. Semin Hematol. 2001 Oct;38(4):333-42. doi: 10.1016/s0037-1963(01)90027-7. Semin Hematol. 2001. PMID: 11605168 Review.

6

Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease.

Gladwin MT, Shelhamer JH, Ognibene FP, Pease-Fye ME, Nichols JS, Link B, Patel DB, Jankowski MA, Pannell LK, Schechter AN, Rodgers GP. Gladwin MT, et al. Br J Haematol. 2002 Feb;116(2):436-44. doi: 10.1046/j.1365-2141.2002.03274.x. Br J Haematol. 2002. PMID: 11841449 Free article.

7

Effects of iron nitrosylation on sickle cell hemoglobin solubility.

Xu X, Lockamy VL, Chen K, Huang Z, Shields H, King SB, Ballas SK, Nichols JS, Gladwin MT, Noguchi CT, Schechter AN, Kim-Shapiro DB. Xu X, et al. Among authors: gladwin mt. J Biol Chem. 2002 Sep 27;277(39):36787-92. doi: 10.1074/jbc.M205350200. Epub 2002 Jul 22. J Biol Chem. 2002. PMID: 12138112 Free article.

8

Imaging hemoglobin oxygen saturation in sickle cell disease patients using noninvasive visible reflectance hyperspectral techniques: effects of nitric oxide.

Zuzak KJ, Gladwin MT, Cannon RO 3rd, Levin IW. Zuzak KJ, et al. Among authors: gladwin mt. Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H1183-9. doi: 10.1152/ajpheart.00243.2003. Epub 2003 Jun 5. Am J Physiol Heart Circ Physiol. 2003. PMID: 12791593 Free article. Clinical Trial.

9

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP. Gladwin MT, et al. N Engl J Med. 2004 Feb 26;350(9):886-95. doi: 10.1056/NEJMoa035477. N Engl J Med. 2004. PMID: 14985486 Free article.

10

Hemolytic anemia-associated pulmonary hypertension in sickle cell disease.

Lin EE, Rodgers GP, Gladwin MT. Lin EE, et al. Among authors: gladwin mt. Curr Hematol Rep. 2005 Mar;4(2):117-25. Curr Hematol Rep. 2005. PMID: 15720960 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

509 results

Search Page

Filters